A Phase III double-blind, randomised, placebo controlled trial of long term therapy on Exacerbation Rate in patients with stable COPD using Doxycycline - Trial 2012-002199-15
Access comprehensive clinical trial information for 2012-002199-15 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Completed. The study focuses on COPD Chronic Obstructive Pulmonary Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2012-002199-15
Completed
Trial Details
EU Clinical Trials Register • 2012-002199-15
A Phase III double-blind, randomised, placebo controlled trial of long term therapy on Exacerbation Rate in patients with stable COPD using Doxycycline
Study Focus
Sponsor & Location
Imperial College London
National Institute for Health Research
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Other chronic obstructive pulmonary disease
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, unspecified
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Chronic obstructive pulmonary disease with acute lower respiratory infection
Data Source
EU Clinical Trials Register
2012-002199-15
Non-Device Trial